CFC launches multi-class policy for medical device market

A syringe is made ready for an injection

BioSurance MD is a multi-class policy targeting key exposures for a wide range of medical device companies involved with the design, development, manufacture or distribution of medical devices of all grades.

Andrew Tamworth, head of life sciences at CFC, said: “This is a unique industry with some very specific exposures and products that can literally mean the difference between life and death.

"Whether making anaesthetic machines or syringes, dentures or stents, these companies need specialist

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected].

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: